Pathophysiology
Clinical meaning
Bone marrow failure syndromes encompass a heterogeneous group of disorders characterized by the inability of the bone marrow to produce adequate numbers of one or more blood cell lineages, resulting in peripheral cytopenias (anemia, neutropenia, thrombocytopenia, or pancytopenia). These disorders are classified as acquired or inherited, with significantly different pathogenic mechanisms, clinical presentations, and treatment approaches. Acquired aplastic anemia (AA) is the most common bone marrow failure syndrome in adults and serves as the prototype for understanding the pathophysiology of marrow failure. In acquired AA, the fundamental mechanism is immune-mediated destruction of hematopoietic stem cells (HSCs) and progenitor cells by autoreactive cytotoxic T lymphocytes (CD8+ T cells). These aberrant T cells recognize and attack HSC surface antigens through perforin-granzyme-mediated cytotoxicity and Fas-FasL-mediated apoptosis, progressively destroying the bone marrow's regenerative capacity. The T cell attack also releases inhibitory cytokines -- interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) -- that further suppress hematopoiesis by upregulating Fas expression on HSCs (making them more susceptible to apoptosis), inhibiting HSC proliferation, and activating intracellular apoptotic pathways. The net result is progressive replacement of hematopoietic marrow...